Key Lumexa Imaging C-suite leader resigns

A key member of Lumexa Imaging’s C-suite has resigned, the publicly traded radiology provider revealed in a recent regulatory filing. 

Julie Szeker, the company’s chief legal officer and corporate secretary, submitted her resignation letter on Jan. 12. Her departure is effective March 13, and the resignation is not the result of any disagreement with Lumexa Imaging relating to its operations, policies or practices. 

The Raleigh, North Carolina-based company—formerly named US Radiology Specialists—said in a Jan. 12 SEC filing that it is now looking for a new CLO.

“We are grateful for Julie Szeker’s more than 10 years of leadership and contributions to Lumexa Imaging and wish her continued success,” a representative told Radiology Business by email Wednesday. “A search for a successor is underway, and the company remains focused on executing its strategic priorities without disruption.”

Szeker first joined the organization in 2018 when it was Charlotte Radiology, according to her LinkedIn profile. That same year, the radiology group formed a joint venture with New York-based private equity firm Welsh, Carson Anderson & Stowe, creating US Radiology Specialists. Last month, the investment group became a minority owner after Lumexa went public on the Nasdaq in a deal valued at $463 million.

Szeker and Lumexa Imaging have entered into a transition agreement, providing her with a payment of $450,000 (equal to 12 months base salary) and up to one year of subsidized healthcare coverage. Such payments are subject to her releasing any claims against of the company, along with complying with the terms of the transition agreement. In addition, she will receive her annual bonus of $250,000, relating to her 2025 performance. Szeker also has agreed not to disclose any private information about the company, nor disparage it in any way after her departure, according to the transition agreement, also filed with the Securities and Exchange Commission.

As chief legal officer, she has overseen legal, risk, compliance and government relations during a period when the company grew its revenue 14 times via organic growth and acquisitions. She has served as a “key thought partner” to Lumexa’s CEO and business operators, “translating legal insights into clear, actionable guidance that drives execution and scale across this national multisite healthcare delivery business,” according to her LinkedIn profile. Prior to joining Charlotte Radiology, Szeker served as associate general counsel and later managing director of business development for the Charlotte-based Carolinas Healthcare System. 

More on company growth

Meanwhile, in a separate announcement shared Jan. 8, Lumexa Imaging touted strong company growth, logged in 2025 prior to its IPO. 

Lumexa set a company record by opening nine newly constructed “de novo” imaging centers last year. Two of the latest are in Anderson, South Carolina, and Cotswold, North Carolina, both opening in December. Following these new additions, Lumexa operates over 185 outpatient imaging centers across 13 states. 

“Our consistent success executing on our de novo strategy, including a record year in 2025, is a testament to our team’s commitment and the value we deliver to patients and stockholders alike,” CEO Caitlin Zulla said in a statement. “In 2026, we aspire to continue advancing healthcare across the country through opening more de novos both independently and with our joint venture partners,” she added later. 

Other new centers opened in 2025 spanned New York, South Carolina and Texas. Lumexa said its outposts seek to capitalize on an aging population and rising tide of chronic conditions by offering extended hours and easily accessible retail locations. The company has sought to target some of the country’s fastest growing metro areas and will continue to do so in 2026. 

Zula previously discussed Lumexa Imaging’s strategy around building new imaging centers last May, with the company originally planning to open 12 in 2025.